Lee Danner & Bass Inc. lowered its position in Express Scripts Holding Company (NASDAQ:ESRX) by 0.1% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 17,727 shares of the company’s stock after selling 19 shares during the period. Lee Danner & Bass Inc.’s holdings in Express Scripts Holding were worth $1,132,000 at the end of the most recent quarter.

Other large investors have also recently modified their holdings of the company. Vanguard Group Inc. raised its stake in shares of Express Scripts Holding by 1.6% in the first quarter. Vanguard Group Inc. now owns 40,251,311 shares of the company’s stock worth $2,652,964,000 after buying an additional 649,400 shares in the last quarter. State Street Corp raised its stake in shares of Express Scripts Holding by 1.1% in the first quarter. State Street Corp now owns 27,060,709 shares of the company’s stock worth $1,783,569,000 after buying an additional 298,341 shares in the last quarter. Barrow Hanley Mewhinney & Strauss LLC raised its stake in shares of Express Scripts Holding by 4.2% in the first quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 17,612,834 shares of the company’s stock worth $1,160,862,000 after buying an additional 704,218 shares in the last quarter. Bank of New York Mellon Corp raised its stake in shares of Express Scripts Holding by 0.3% in the first quarter. Bank of New York Mellon Corp now owns 10,960,709 shares of the company’s stock worth $722,420,000 after buying an additional 32,854 shares in the last quarter. Finally, Macquarie Group Ltd. raised its stake in shares of Express Scripts Holding by 2.8% in the first quarter. Macquarie Group Ltd. now owns 10,958,513 shares of the company’s stock worth $722,275,000 after buying an additional 296,452 shares in the last quarter. Institutional investors and hedge funds own 90.24% of the company’s stock.

Express Scripts Holding Company (ESRX) opened at 60.79 on Friday. Express Scripts Holding Company has a 1-year low of $57.80 and a 1-year high of $77.50. The firm has a market capitalization of $35.11 billion, a P/E ratio of 10.55 and a beta of 0.90. The company’s 50-day moving average price is $61.89 and its 200-day moving average price is $63.95.

Express Scripts Holding (NASDAQ:ESRX) last announced its earnings results on Tuesday, July 25th. The company reported $1.73 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.71 by $0.02. The company had revenue of $25.35 billion during the quarter, compared to the consensus estimate of $25.52 billion. Express Scripts Holding had a net margin of 3.50% and a return on equity of 25.58%. Express Scripts Holding’s revenue was up .5% compared to the same quarter last year. During the same period last year, the firm earned $1.57 earnings per share. Equities research analysts expect that Express Scripts Holding Company will post $6.99 earnings per share for the current fiscal year.

TRADEMARK VIOLATION WARNING: This article was posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this article on another domain, it was copied illegally and reposted in violation of U.S. & international copyright and trademark legislation. The legal version of this article can be viewed at https://www.thecerbatgem.com/2017/08/27/lee-danner-bass-inc-reduces-stake-in-express-scripts-holding-company-esrx.html.

A number of equities research analysts have commented on the company. Cowen and Company reiterated an “outperform” rating and issued a $83.00 price target on shares of Express Scripts Holding in a research report on Friday, June 9th. BidaskClub lowered Express Scripts Holding from a “hold” rating to a “sell” rating in a research report on Wednesday, July 12th. ValuEngine lowered Express Scripts Holding from a “buy” rating to a “hold” rating in a research report on Friday, June 2nd. Needham & Company LLC assumed coverage on Express Scripts Holding in a research report on Friday, July 21st. They issued a “hold” rating on the stock. Finally, Morgan Stanley upped their price target on Express Scripts Holding from $52.00 to $57.00 and gave the company an “underweight” rating in a research report on Thursday, August 10th. Four research analysts have rated the stock with a sell rating, thirteen have given a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. The stock currently has an average rating of “Hold” and an average target price of $71.17.

In other Express Scripts Holding news, VP Everett Neville sold 1,163 shares of the firm’s stock in a transaction that occurred on Wednesday, August 23rd. The shares were sold at an average price of $61.48, for a total value of $71,501.24. Following the completion of the sale, the vice president now directly owns 18,232 shares in the company, valued at $1,120,903.36. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. 0.68% of the stock is owned by company insiders.

About Express Scripts Holding

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

Want to see what other hedge funds are holding ESRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Express Scripts Holding Company (NASDAQ:ESRX).

Institutional Ownership by Quarter for Express Scripts Holding (NASDAQ:ESRX)

Receive News & Stock Ratings for Express Scripts Holding Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Company and related stocks with our FREE daily email newsletter.